Showing results (181-190 of 295) with videos related to

Sort By:
Pageof 30
Biorxiv : the Preprint Server for Biology|August 21, 2020
Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell cultureKenneth H Risner, Katie V Tieu, Yafei Wang, et al.
Pulmonary Circulation|July 10, 2023
Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real-world patient data repositoryHarrison W Farber, Murali M Chakinala, Michelle Cho, et al.
Respiratory Research|November 11, 2022
A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung diseaseToby M Maher, Courtney Schiffman, Michael Kreuter, et al.
Critical Care Explorations|February 10, 2023
Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19-Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization RegistryAbhimanyu Chandel, Nitin Puri, Emily Damuth, et al.
BMJ Open Respiratory Research|August 18, 2018
Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trialsSteven D Nathan, Lisa H Lancaster, Carlo Albera, et al.
Pulmonary Circulation|April 7, 2023
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary HypertensionLucilla Piccari, Brian Allwood, Katerina Antoniou, et al.
The European Respiratory Journal|July 3, 2025
Development and validation of a predictive 6-minute walk score in patients with Idiopathic Pulmonary FibrosisSteven D Nathan, Jie Gao, Ho Cheol Kim, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|December 1, 2005
A critical assessment of treatment options for idiopathic pulmonary fibrosisNirav R Shah, Paul Noble, Robert M Jackson, et al.
Respiratory Medicine|June 2, 2019
Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairmentSteven D Nathan, Ulrich Costabel, Carlo Albera, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2014
All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trialsTalmadge E King, Carlo Albera, Williamson Z Bradford, et al.
Pageof 30